Cancer classification and functional pathway discovery using TCGA transcriptomic profiles: A matched case-control framework

Leveraging high-dimensional transcriptomic data from The Cancer Genome Atlas (TCGA) for cancer classification holds critical significance for advancing precision oncology. Matched Case-control Design (MCCD), by pairing similar cases with controls, can enhance statistical power and reduce confounding bias. However, high-dimensional data present challenges such as overfitting, instability, and difficulty in interpretation, collectively referred to as the "curse of dimensionality." Feature selection can help mitigate these problems by identifying representative variables and reducing redundancy. This study's innovation lies in integrating a set of existing techniques into a unified analytical workflow tailored specifically for MCCD, validated through both simulated and real TCGA datasets. We compared the performance of paired versus unpaired feature selection approaches under simulated 1:1 MCCD scenarios, and developed a modular, pluggable pipeline. This includes mean-centering, gene filtering, and a Corrected Feature Matrix (CFM) transformation step that explicitly preserves the matched structure. This transformation is then combined with machine learning classifiers to predict cancer status. We also incorporated Incremental Feature Selection (IFS) to refine gene subsets and employed gene set enrichment analysis to enhance biological interpretability. While the individual components we used, such as paired testing, CFM, IFS, and model-based gene set analysis, are not novel in themselves, we demonstrate an integrated workflow optimized for MCCD tasks. This workflow outperforms uncorrected approaches in terms of classification accuracy, feature stability, and interpretability. Our results indicate that this method can enhance cancer classification accuracy, facilitate biomarker discovery, and aid in building interpretable diagnostic models, providing a practical and scalable tool for precision medicine.

Authors

Institutions

Publication Details

Journal
Journal of Bioinformatics and Computational Biology
Published
2025-09-22
DOI
https://doi.org/10.1142/s0219720025500155
Citations
1
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cancer classification and functional pathway discovery using TCGA transcriptomic profiles: A matched case-control framework

Po-Lin Hou, Tao Guo, Yu-Min Pai, Jie-Huei Wang et al.
1 citations
Journal of Bioinformatics and Computational Biology
Cancer Genomics and Diagnostics
0.94
article

Cancer classification and functional pathway discovery using TCGA transcriptomic profiles: A matched case-control framework

Po-Lin Hou, Tao Guo, Yu-Min Pai, Jie-Huei Wang, Michael W.Y. Chan, Hemlata Kumari
article en
1 citations

Abstract

Leveraging high-dimensional transcriptomic data from The Cancer Genome Atlas (TCGA) for cancer classification holds critical significance for advancing precision oncology. Matched Case-control Design (MCCD), by pairing similar cases with controls, can enhance statistical power and reduce confounding bias. However, high-dimensional data present challenges such as overfitting, instability, and difficulty in interpretation, collectively referred to as the "curse of dimensionality." Feature selection can help mitigate these problems by identifying representative variables and reducing redundancy. This study's innovation lies in integrating a set of existing techniques into a unified analytical workflow tailored specifically for MCCD, validated through both simulated and real TCGA datasets. We compared the performance of paired versus unpaired feature selection approaches under simulated 1:1 MCCD scenarios, and developed a modular, pluggable pipeline. This includes mean-centering, gene filtering, and a Corrected Feature Matrix (CFM) transformation step that explicitly preserves the matched structure. This transformation is then combined with machine learning classifiers to predict cancer status. We also incorporated Incremental Feature Selection (IFS) to refine gene subsets and employed gene set enrichment analysis to enhance biological interpretability. While the individual components we used, such as paired testing, CFM, IFS, and model-based gene set analysis, are not novel in themselves, we demonstrate an integrated workflow optimized for MCCD tasks. This workflow outperforms uncorrected approaches in terms of classification accuracy, feature stability, and interpretability. Our results indicate that this method can enhance cancer classification accuracy, facilitate biomarker discovery, and aid in building interpretable diagnostic models, providing a practical and scalable tool for precision medicine.

Journal of Bioinformatics and Computational BiologyVol. 23(05)
National Chung Cheng University (TW)
Openalex Percentile: Top 20%
Cancer Genomics and Diagnostics
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.